<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="497">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05154682</url>
  </required_header>
  <id_info>
    <org_study_id>AILY 21D.615</org_study_id>
    <nct_id>NCT05154682</nct_id>
  </id_info>
  <brief_title>Pain Management After Surgery</brief_title>
  <official_title>Multi-Modal Pain Management After Outpatient Orthopaedic Surgery: A Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rothman Institute Orthopaedics</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rothman Institute Orthopaedics</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Following outpatient orthopaedic surgery, adequate pain control is imperative both for&#xD;
      patient satisfaction and for improved recovery and rehabilitation. Opioids are frequently&#xD;
      utilized for postoperative pain control, however they can be addictive and are known to have&#xD;
      many deleterious effects. Recent studies have demonstrated the effectiveness of a wide&#xD;
      variety of multi-modal postoperative pain regimens in providing adequate pain control while&#xD;
      also decreasing opioid usage. However, the most effective multi-modal pain regimen for&#xD;
      postoperative pain control remains unclear. This prospective, randomized study intends to&#xD;
      investigate the efficacy of a multi-modal postoperative pain regimen compared to a&#xD;
      traditional opioid-only pain regimen following elective outpatient orthopaedic surgery of the&#xD;
      hand, wrist, foot, or ankle.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">November 30, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>14 days</time_frame>
    <description>With the use of an 11 point numeric rating scale (NRS) daily satisfaction with their pain regimen, patients pain level and medication usage will be recorded.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Oxycodone Group (Control Group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive oxycodone as needed after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone+ Naproxen/Acetaminophen (Study Group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>each patient will receive oxycodone plus acetaminophen and naproxen for 2 weeks after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>OxyCODONE 5 mg Oral Tablet</intervention_name>
    <description>Oxycodone will be given every 4 hours as needed for 2 weeks after surgery</description>
    <arm_group_label>Oxycodone Group (Control Group)</arm_group_label>
    <arm_group_label>Oxycodone+ Naproxen/Acetaminophen (Study Group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen 500Mg Tab</intervention_name>
    <description>Acetaminophen will be taken every 4 hours for 2 weeks after surgery</description>
    <arm_group_label>Oxycodone+ Naproxen/Acetaminophen (Study Group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naproxen 500 Mg</intervention_name>
    <description>Naproxen will be taken every 12 hours for 2 weeks after surgery</description>
    <arm_group_label>Oxycodone+ Naproxen/Acetaminophen (Study Group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥ 18 years old&#xD;
&#xD;
          -  undergoing elective outpatient orthopaedic surgery under general anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years old&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
          -  allergy to or medical contraindication to taking oxycodone (or other opioids),&#xD;
             acetaminophen, or Naprosyn (or other NSAIDs).&#xD;
&#xD;
          -  currently taking opioid medications&#xD;
&#xD;
          -  history of chronic opioid therapy for chronic pain&#xD;
&#xD;
          -  surgery being performed under local anesthesia only, without general anesthesia or&#xD;
             sedation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rothman Orthopaedic Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 30, 2021</study_first_submitted>
  <study_first_submitted_qc>November 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Naproxen</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

